|
1
|
Ohmes LB, Di Franco A, Di Giammarco G,
Rosati CM, Lau C, Girardi LN, Massetti M and Gaudino M: Techniques
for intraoperative graft assessment in coronary artery bypass
surgery. J Thorac Dis. 9 Suppl 4:S327–S332. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Raja SG: Two decades of off-pump coronary
artery bypass surgery: Harefield experience. J Thorac Dis. 8 Suppl
10:S824–S828. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
He GW and Taggart DP: Antispastic
management in arterial grafts in coronary artery bypass grafting
surgery. Ann Thorac Surg. 102:659–668. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ward AO, Caputo M, Angelini GD, George SJ
and Zakkar M: Activation and inflammation of the venous endothelium
in vein graft disease. Atherosclerosis. 265:266–274. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Meng F, Ma J, Wang W and Lin B:
Meta-analysis of interleukin 6, 8, and 10 between off-pump and
on-pump coronary artery bypass groups. Bosn J Basic Med Sci.
17:85–94. 2017.PubMed/NCBI
|
|
6
|
Lee W, Park KD, Han KD, Suh H, Park JC and
Kim YH: Heparinized bovine pericardium as a novel cardiovascular
bioprosthesis. Biomaterials. 21:2323–2330. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nosalski R and Guzik TJ: Perivascular
adipose tissue inflammation in vascular disease. Br J Pharmacol.
174:3496–3513. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lénárt N, Brough D and Dénes Á:
Inflammasomes link vascular disease with neuroinflammation and
brain disorders. J Cereb Blood Flow Metab. 36:1668–1685. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Amlie-Lefond C and Shaw D: Vascular
disease. Handb Clin Neurol. 136:1159–1171. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
de Franciscis S, Metzinger L and Serra R:
The Discovery of novel genomic, transcriptomic, and proteomic
biomarkers in cardiovascular and peripheral vascular disease: The
state of the art. BioMed Res Int. 2016:78291742016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lukitsch I, Kehr J, Chaykovska L, Wallukat
G, Nieminen-Kelhä M, Batuman V, Dragun D and Gollasch M: Renal
ischemia and transplantation predispose to vascular constriction
mediated by angiotensin II type 1 receptor-activating antibodies.
Transplantation. 94:8–13. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yin H and Pickering JG: Cellular
senescence and vascular disease: Novel routes to better
understanding and therapy. Can J Cardiol. 32:612–623. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moore TM and Gendler E and Gendler E:
Viruses adsorbed on musculoskeletal allografts are inactivated by
terminal ethylene oxide disinfection. J Orthop Res. 22:1358–1361.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cheshire PA, Herson MR, Cleland H and
Akbarzadeh S: Artificial dermal templates: A comparative study of
NovoSorb™ Biodegradable Temporising Matrix (BTM) and
Integra(®) Dermal Regeneration Template (DRT). Burns.
42:1088–1096. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Han Y, Choo SJ, Kwon H, Lee JW, Chung CH,
Kim H, Kwon TW and Cho YP: Effects of upper-extremity vascular
access creation on cardiac events in patients undergoing coronary
artery bypass grafting. PLoS One. 12:e01841682017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Weldon JE, Xiang L, Zhang J, Beers R,
Walker DA, Onda M, Hassan R and Pastan I: A recombinant immunotoxin
against the tumor-associated antigen mesothelin reengineered for
high activity, low off-target toxicity, and reduced antigenicity.
Mol Cancer Ther. 12:48–57. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Patris E, Giakoumidakis K, Patris V,
Kuduvalli M, Argiriou M, Charitos C, Kalaitzis C and Touloupidis S:
Perioperative prostate specific antigen levels among coronary
artery bypass grafting patients: Does extracorporeal circulation
and body temperature induce prostate specific antigen levels
alterations? Urol Ann. 7:58–62. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Opfermann P, Derhaschnig U, Felli A,
Wenisch J, Santer D, Zuckermann A, Dworschak M, Jilma B and
Steinlechner B: A pilot study on reparixin, a CXCR1/2 antagonist,
to assess safety and efficacy in attenuating ischaemia-reperfusion
injury and inflammation after on-pump coronary artery bypass graft
surgery. Clin Exp Immunol. 180:131–142. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Müller S, Rihs S, Schneider JM, Paredes
BE, Seibold I, Brunner T and Mueller C: Soluble TNF-alpha but not
transmembrane TNF-alpha sensitizes T cells for enhanced
activation-induced cell death. Eur J Immunol. 39:3171–3180. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo ZP, Hou HT, Jing R, Song ZG, Liu XC
and He GW: Plasma protein profiling in patients undergoing coronary
artery bypass grafting surgery and clinical significance.
Oncotarget. 8:60528–60538. 2017.PubMed/NCBI
|
|
21
|
Abraham AC, Shah SA and Thomopoulos S:
Targeting inflammation in rotator cuff tendon degeneration and
repair. Tech Shoulder Elbow Surg. 18:84–90. 2017. View Article : Google Scholar
|
|
22
|
Kimura T, Tse K, McArdle S, Gerhardt T,
Miller J, Mikulski Z, Sidney J, Sette A, Wolf D and Ley K:
Atheroprotective vaccination with MHC-II-restricted ApoB peptides
induces peritoneal IL-10-producing CD4 T cells. Am J Physiol Heart
Circ Physiol. 312:H781–H790. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schmid PM, Bouazzaoui A, Schmid K, Birner
CM, Schach C, Maier LS, Holler E and Endemann DH: Vascular
alterations in a murine model of acute graft-versus-host disease
are associated with decreased serum levels of adiponectin and an
increased activity and vascular expression of indoleamine
2,3-dioxygenase. Cell Transplant. 25:2051–2062. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mazzaccaro D, De Febis E, Settembrini AM,
Tassinari L, Carmo M and Settembrini PG: Long-term results of PTFE
trilaminate graft versus venous graft and composite graft for
below-the-knee revascularization. J Cardiovasc Surg (Torino).
55:685–691. 2014.PubMed/NCBI
|
|
25
|
Malinska A, Podemska Z, Sujka-Kordowska P,
Witkiewicz W, Nowicki M, Perek B and Witt M: Caveolin 2: A
facultative marker of unfavourable prognosis in long-term patency
rate of internal thoracic artery grafts used in coronary artery
bypass grafting. Preliminary report. Interact Cardiovasc Thorac
Surg. 24:714–720. 2017.PubMed/NCBI
|
